Clinical trial
Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients…
NCT00321113 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00321113 |
|---|---|
| Title | Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys |
| Official title | An Open, Multicentre, Randomised, Parallel Group Study to Compare in Marginal Old-for-old Renal Transplant Patients the Safety and Efficacy of Two Treatments: Sequential Mycophenolate Mofetil/Delayed Tacrolimus Plus Steroids vs Tacrolimus Plus Mycophenolate Mofetil in Patients Requiring Induction… |
| Acronym | TIGRE |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | KIDNEY TRANSPLANTATION |
| Intervention type | Drug |
| Interventions | tacrolimus, mycophenolate mofetil, steroids |
| Enrollment | 142 |
| Start date | Sep 1, 2004 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | May 3, 2006 |
| Last update posted | Feb 24, 2017 |
| Countries | Italy |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: